Anti-human ovarian cancer immunotoxins and methods of use...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/129

A61K 39/00 (2006.01) A61K 47/48 (2006.01) C07K 16/30 (2006.01) A61K 38/00 (2006.01)

Patent

CA 1289880

-38- Abstract of the Disclosure Immunotoxins comprising a cytotoxic moiety and monoclonal antibodies which bind to human ovarian cancer tissue having at least one of the following capabilities are claimed: cytotoxic ID50 of 10 nM or less against human ovarian cancer cells, retardation of human ovarian cancer tumor growth in mammals or extension of survival of a mammal carrying a human ovarian cancer tumor. Antigens to which the monoclonal antibody of the immunotoxin bind are identified and characterize the immunotoxins. Methods of killing human ovarian cancer cells, retarding the growth of human ovarian cancer tumors in mammals or extending the survival of mammals carrying human ovarian cancer tumors are claimed.

523992

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anti-human ovarian cancer immunotoxins and methods of use... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-human ovarian cancer immunotoxins and methods of use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-human ovarian cancer immunotoxins and methods of use... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1244888

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.